Definitions
Sorry, no definitions found. You may find more data at sprycel.
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word Sprycel.
Examples
-
Bristol-Myers also is researching possible additional uses for Sprycel, which is approved for chronic myeloid leukemia, and Erbitux, approved for head and neck cancers.
-
Bristol-Myers also is researching possible additional uses for Sprycel, which is approved for chronic myeloid leukemia, and Erbitux, approved for head and neck cancers.
-
Bristol-Myers also is researching possible additional uses for Sprycel, which is approved for chronic myeloid leukemia, and Erbitux, approved for head and neck cancers.
-
Dr. Sawyers, a Howard Hughes Medical Institute investigator, played important roles in the development of Novartis AG's breakthrough leukemia drug Gleevec and a second-generation version called Sprycel from Bristol-Myers Squibb Co.
Gaining on Prostate Cancer Ron Winslow 2012
-
Bristol-Myers also is researching possible additional uses for Sprycel, which is approved for chronic myeloid leukemia, and Erbitux, approved for head and neck cancers.
-
Tasigna will compete with a Bristol-Myers Squibb Co. drug called Sprycel, which also treats CML patients who don't respond to Gleevec.
-
The team also showed LOX was activating a molecule called SRC to promote cancer growth and spread -- a finding that led them to look at Sprycel, which is known to block SRC function and is already being used to treat patients with chronic myeloid leukemia, or CML.
-
And the company also has data on several drugs coming out soon, including a study testing its Sprycel, which is approved for patients with chronic myeloid leukemia who weren't helped by other treatments, in patients newly diagnosed with the cancer.
Fore, right! 2010
-
And the company also has data on several drugs coming out soon, including a study testing its Sprycel, which is approved for patients with chronic myelogenous leukemia who weren't helped by other treatments, in patients newly diagnosed with the cancer.
The Seattle Times 2010
-
And the company also has data on several drugs coming out soon, including a study testing its Sprycel, which is approved for patients with chronic myelogenous leukemia who weren't helped by other treatments, in patients newly diagnosed with the cancer.
R&D Mag - News 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.